Author

Frances Wells

Institutions: Center for Biologics Evaluation and Research, United States Food and Drug Administration

Observed institutions: National Institutes of Health, Center for Biologics Evaluation and Research, United States Food and Drug Administration, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, Vaccine Research Center

OpenAlex ID: A5111865555

Inhibition of Hepatitis C Virus by the Cyanobacterial Protein Microcystis viridis Lectin: Mechanistic Differences between the High-Mannose Specific Lectins MVL, CV-N, and GNA

2013 · Alla Kachko, Sandra Loesgen, et al. · Molecular Pharmaceutics · 48

New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles

2011 · Alla Kachko, Galina Kochneva, et al. · Vaccine · 34

Hepatitis C virus clearance correlates with HLA-DR expression on proliferating CD8+ T cells in immune-primed chimpanzees

2013 · Iryna Zubkova, Hongying Duan, et al. · Hepatology · 25

Antibodies to an interfering epitope in hepatitis C virus E2 can mask vaccine‐induced neutralizing activity

2015 · Alla Kachko, Sharon E. Frey, et al. · Hepatology · 22

Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry

2018 · Alla Kachko, Maria Isabel Costafreda, et al. · Journal of Virology · 17

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens

2017 · Wendy G. Tan, Iryna Zubkova, et al. · PLoS ONE · 10

Works count: 6

Citation count: 156

H-index: 6

I10-index: 6